throbber
Measurement of ammonia in blood
`
`Robert J Bamatn; MD
`
`The measurement of ammonia. now ltnown to be a normal constituent of all
`
`
`
`body fluids, is Fraught with problems. An elevated ammonia level in blood
`(100 y.molfL or higher) is an indicator of an abnormality in nitrogen home»-
`ostasis. The collection, handling, storage, and analysis of blood samples.
`their limitations, and potential sources of error are discussed. New tech»
`niques that permit continuous or real-time estimates of systemic ammonia
`levels over a broad range are also discussed. The aim should aiways be to
`minimize the release of ammonia From the collected sample before analysis.
`Recommendations are made on the collection and processing of blood sam-
`ples, for it is by standardization and rigid adherence to these techniques
`that the reliability of the test results will be improved. (J Pediatr 2001:
`138:S1l-S20)
`
`Ammonia is novv considered a normal
`
`constituent of all body fluids, resulting
`from the metabolism of amino acids.
`
`However, doubts of the presence of
`Free ammonia in biologic solutions per-
`sisted until approximately 1960. Before
`this time the various methods available
`for the determination of ammonia con-
`
`tent in biologic fluids relied on the sep-
`aration or release :3? ammonia From the
`
`Fluid sample by volatilization after the
`addition ofan alkaline solution. With
`these methods, increased levels of am-
`
`monia had been reported in the blood
`of patients with severe hepatic Failure.
`Despite such reports. doubts about the
`presence of Free ammonia in blood con»
`tinued, mainly as a result of the con-
`cern that Free ammonia measured by
`these methods resulted From its libera-
`
`tion from labile amides in blood during
`incubation in alkaline solutions. Defin-
`
`itive proof was provided by studies
`showing that the enzyme glutamine de-
`hydrogenase specifically reacts with
`ammonia. (1.-ketoglutarate. and a coen-
`zyme. reduced nicotinamide-adenine
`dinucleotide, to Form glutamic acid.‘
`This reaction has become the basis for
`
`the most commonly used blood ammo-
`nia assay in clinical chemistry. One of
`the attractive features of this assay is
`that ammonia is determined directly at
`physiological pH without previous
`treatment of the sample with either an
`acid or a base.“
`
`Today, an elevated ammonia blood
`level is considered a strong indicator ol'
`an abnormality in nitrogen homeostasis.
`the flilost Cofllnlon related. to liver dy5'
`Function. In excess, ammonia is a potent
`toxin, principally of central nervous
`system limction. In the venous blood of
`healthy adults and children. blood am-
`
`ll‘ iimrnna Jafirrann ffnnrraiy, Pfiiirrflcfpbiir, Pann.:_u1mn.r'n.
`From the Dcpnrfnrcni agf Pat."£\I1.'irJg_y;
`Reprint requests: Robert J. Barsotti. PhD, Associate Professor, Deparrrnent of Pathology, Anato-
`my and Cell Biology. Thomas Jefferson Universiiy. 1020 Locust St, Philadelphia. PA 19107.
`Copyright @ 2001 by Mosby. Inc.
`0022-3476l20Gl)’$55.U{l + {J
`930/111852
`
`doi:lU.l057fn1pd.2U0l.l11332
`
`monia levels are approximately 30
`Llmol/L, and levels exceeding 1 mmolfl.
`occur under conditions of acute hyper-
`ammonemia.“ Over the past lU0years.
`numerous methods have been devel-
`
`oped to measure ammonia levels in var-
`ious body iluids including blood. plas-
`ma. erythrocytes, saliva, sweat. and
`urine.6 This briel’ review considers a
`Few of the most common methods cur-
`
`rently used to measure ammonia in
`blood: alkalization~diiFusion, enzymat-
`ic. ion exchange. and electrode. Sample
`collection, handling, storage. and some
`ol" the limitations and potential sources
`of errors associated with these methods
`
`are discussed. Finally, some promising
`novel techniques for the continuous
`monitoring of ammonia levels that may
`be used clinically in the near Future are
`also described.
`
`GLDH
`NADH
`
`Glmamine dehyclrogenase
`Reduced nicoiinamicle-adenine
`dlnudeotlde
`NADPH Reduced nicotiriamitle adenine
`dlnudeotlde phosphate
`Selected-Ion flow tube
`
`S|Fl'
`
`PREANALYTICAL
`
`METHOD Fon
`
`HANDLING BLOOD
`
`AMMoNIA
`
`DETERMINATION
`
`SAMPLES
`
`Most methods recommend collecting
`From‘ patients who have fasted for at
`least 6 hours with the use of a verified
`
`ammonia-Free heparin as an anticoagu-
`lant. Heparin is the preferred anticoag-
`ulant, because it has been shown to
`
`reduce red blood cell ammonia produc-
`
`SH
`
`LUPIN EX. 1015
`
`1of10
`
`1 of 10
`
`

`

`BARSOTTI
`
`pl-I Dependence of the Fraction of the ionized Fonn
`of Ammonia in Solution
`
`I
`
`.
`
`I.D|l
`
`PS
`
`P8
`
`PF’BS
`
`
`
`NH‘?NH,Ratio
`
`
` 7.0 8.!)
`SJ
`19.0
`11.U
`
`Fry 1'. Ratio between ionized and free gas form of ammonia in piasrna as function of pH.
`
`exclusively with blood specimens From
`healthy sul.>jects.8 Significantly more
`diliicult but much more constructive
`would be the establishment oilsimilar
`criteria for blood ammonia measure-
`
`ments lrom patients with metabolic or
`liver pathologic conditions. Standing
`blood or plasma samples From these
`patients Contain numerous elevated
`sources oi‘ ammonia. resulting in in-
`creases in the rate and amount ol‘ am-
`monia formed. Some of‘ these sources
`
`include elevated levels of circulating
`deaminase. Y-glutamyltransferase. an
`enzyme that may deaminate free amino
`acids. particularly glutamine in blood
`and plasma samples, resulting in over-
`estimates ol' blood ammonia levels.
`
`Fast. careful handling and preparation
`of blood samples is required. especially
`from patients with metabolic or liver
`pathologic conditions, to minimize pre-
`analysis increases in ammonia concen-
`tration until other assay techniques or
`methods are developed. Until this is
`accomplished. measurements in this
`patient population. in which blood an-I-
`monia levels require the closest moni-
`toring. will continue to be the most un-
`reliable. To date, the easiest and most
`
`tion. EDTA can also be used. I)onors'
`
`arms should be as relaxed as possible.
`because muscle exertion may increase
`venous ammonia levels}? Blood is
`
`drawn into a chilled. heparinized vacu-
`um tube that is immediately placed on
`ice. and plasma is separated within 15
`minutes. It is crucial to keep blood
`samples cold alter collection, because
`the ammonia concentration olistanding
`blood and plasma increases sponta-
`neously. Nlost ol‘ this increase has been
`attributed to the generation and re~
`lease of‘ ammonia from red blood cells
`and the deamination of‘ amino acids,
`
`particularly glutamine.3‘“ Plasma am-
`monia levels OI‘ whole blood main-
`tained at 4“C are stable for <1 hour.
`
`When promptly separated From blood.
`plasma ammonia levels are stable at
`4“C for 4 hours and For 24 hours ii‘
`
`stored froacen at —'20"C. To put the
`problem of‘ rising ammonia levels in
`perspective, the total nitrogen concen-
`tration in venous plasma oi‘ healthy
`adults exceeds l molfl. and represents
`a potential pool of free blood ammo-
`nia.'2 In normal healthy adults, homeo-
`stasis maintains lree ammonia levels at
`
`approximately 50 ttmol/L.
`It is important to note that the crite-
`ria For sample stability and the meth-
`ods i'or the measurement oi’ ammonia
`levels in blood were established almost
`
`Sl2
`
`THE JOURNAL OF PEDIATRICS
`JANUARY 200i
`
`ANALYTICAL METHODS
`
`FORTHE
`
`DETERMINATION OF
`
`AMMONIA
`
`Nlany oiithe procedures for ammonia
`determination involve 2 general steps:
`the release oi‘ ammonia gas or capture
`of ammonium ions from the sample
`and the quantitation ol’ the liberated
`gas or captured ions. Over the years
`the most common methods used to
`volatilize ammonia have been distilla-
`tion and aerationfmicrodil'l‘usion. ion-
`
`exchange chromatography, and blood
`or plasma deproteinization.
`
`Properttiea of/lnmwrtfa
`In attempting to understand the ra~
`tionale used to measure ammonia. it is
`
`important to review some oi‘ the physi-
`cal properties ol‘ the compound. Arn-
`monia (NH3)
`is a colorless. acrid-
`SITI{’.‘iiing gas at roof“ ‘l.'CTI"IpCratuT'C and
`pressure. It easily dissolves in water
`and ion izes to Form l\lH_,‘ as Follows:
`
`NH3 + H202 NH4'+ OH‘
`
`An increase in the pH or tempera-
`ture of the solution increases the level
`
`OF the ionized Form. Fig l shows the
`ratio that exists in plasma between the
`ionized or NH4' Form versus the
`gaseous or NH3 l‘orm as a liunction oi‘
`pH. Thus in plasma at pH 7.4.
`the
`NH4‘ Form represents approximately
`98% ofthe total ammonia. Many ofthe
`approaches used to estimate ammonia
`levels in body fluids involve volatili7.a-
`tion ol‘ the t\lH_1* ibrm oiiammonia into
`its gaseous iorm. NH5 ,by alitalization
`ofthe sample to a pH >10.
`
`Dtlrttfla tion
`
`One o|'the earliest techniques For the
`measurement oliammonia involves the
`addition ol"an all-taline buller to a sam-
`
`cost—ei‘l‘ective method is the stringent
`and diligent maintenance oi‘ blood
`samples on ice before. during, and
`alter plasma separation.
`
`ple oi‘ blood followed by in Vacuo dis-
`tillation. ’l‘he released ammonia gas is
`collected in at
`trap containing an
`aliquot ol-1 dilute acid. which converts
`
`2of10
`
`2 of 10
`
`

`

`THE ]OURNAL or PEDIATRICS
`VOLUME I38, NUMBER I
`
`the gas into the nonvolatile ammonium
`ion. This approach is rather cumber-
`some and slow. particularly when
`ulany Salrlples require analysis,
`3.!‘-
`though initially, speed was the primary
`advantage of this approach over the
`early microdilil-‘usion techniques de-
`scribed in the Following text. This ad-
`vantage, however. was temporary, and
`was lost with the development of
`smaller microdifliusion vessels. The last
`
`reported use of distillation was by
`Burg and Mock” in 1965.
`
`Aenzttion/Jficmfli radian
`Tecihniqued
`Another early technique that is still
`in use relies on liberation of Free am-
`
`monia by alkalization by the addition
`ofa strong base to the specimen. The
`released ammonia diFFuses through an
`air- or nitrogen-Filled gap and is
`trapped in acid within the same appa-
`ratus. This approach, introduced by
`Conway and Berne” in 1953, uses a
`glass container resembling a Petri dish.
`within which a smaller second cham-
`ber is centered. The wall of this inner
`
`chamber is approximately half of that
`of the outside wall. An aliquot of a
`standard acid solution or ammonia in-
`
`dicator such as bromocresol green is
`placed into the inner chamber, and the
`sample is added to the outer chamber
`(Fig 2). A measured quantity of base is
`added to the sample, and the "petri”
`dish is sealed and gently rotated to mix
`the sample and base in the outer cham-
`ber and then left at room temperature
`For 90 minutes. This same principle is
`used in the Blood Ammonia Check»
`erl5"fi and in the Kodak Ektachem
`
`dry-film method.” In these systems
`the diffusion distance For ammonia is
`
`significantly reduced From those in the
`original diffusion apparatus of Conway
`and Berne, requiring only 5 minutes to
`complete (Fig 5).
`Distillation and rnicrodiffusion both
`
`represent purification procedures that
`isolate ammonia From the many other
`constituents of blood and plasma, re»
`ducing the possible effects of other
`
`BARSOTTI
`
`Image available
`in print only
`
`Fly 2. Early miuodiffiision apparatus fordelrermination of blood ammonia. {Reproduced with per-
`mission from Conway E. Byrne A. An absorption apparatus for the micro-detennination of ammonia.
`Biochem J.
`|993‘,27:4 I 9-29. © ‘me Biochemical Society.)
`
`Current Micro-diffusion Apparatus
`
`Sample cornpertrnenl
`
`Tablet (Alkaline Buffer)
`
` Polyethylene fllm
`
`Illustration of microdiffusion technique used in Blood Ammonia Checker‘. (Reproduced with
`Fig}.
`permission fromTada K Okuda K.Watanabe K. et a|.A new method for screening for hyperam-
`monemia. Eur] Pediafl: |979:|30:|05-I0.)
`
`constituents and drugs on the ammo-
`nia assay. One main drawback of these
`procedures is that varying amounts of
`ammonia are liberated from the alka-
`
`line hydrolysis of proteins, especially
`hemoglobin, and labile amides. espe-
`cially glutarnine.'3'2"
`
`Ion-Excihange Clhmnzatagrapliy
`In this approach ammonia gas is not
`liberated from the sample. instead, a
`strongly acidic catiomexchange resin
`is used in batch mode to capture am-
`monium ions, NH4‘. The resin is
`added to and subsequently separated
`From the sample by centril'i.1gation. and
`the captured ammonium ions are then
`eluted From the resin by salt solutions
`or released as ammonia by the addi-
`tion of dilute alkali,” a technique de-
`scribed in detail more recently by
`Brusilowfl
`
`Deproteinézafion
`Whole blood or plasma proteins are
`precipitated by the addition of tri-
`chloroacetic or perchloric acids, and the
`ammonia is determined directly in the
`supernatant fluid after alltalization.22'25
`
`QUANTITATION OF
`AMMONIA
`
`After the release or capture of ammo-
`nia or ammonium ions, several methods
`have been described to determine the
`
`amount of ammonia present. The gen-
`eral categories For these methods in-
`clude titration, colorimetric;’fiuorimet-
`
`ric, electrode-baseds and enzymatic.
`
`Titration Memo?
`The ammonia liberated from the
`
`sample is trapped in an aliquot of di-
`
`SI3
`
`3of10
`
`3 of 10
`
`

`

`BARSOTTI
`
`THE JOURNAL or PEDIATRICS
`JANUARY 200|
`
`Temperature controlled
`
`Box \
`
`Gas Sensing Electrode
`ltnhranc: Elaclmde
`
`pl-I niaeirorln
`
` pt-I Eullar
`
`Helurence Buflel
`Gas Pcrrnefile Membrane
`[water imptmrlaua]
`
`
`
`4-“ Sample
`
`4— manna Buffer
`
`Sealed Mixing churn bar
`
`Fry -7. Sthematic of ion-selective electrode (left panel) and suggested arrangement for continuous-flow analysis of ammonia
`in plasma samples {right panel).
`
`lute acid. and the amount is measured
`
`by back-titration ol. the acid solution
`with a base while the pH is monitored
`with an indicator or electrode. The
`
`principal advantage oi‘ this approach is
`that it is inexpensive, requiring no spe-
`cialized equipment. The disadvan-
`tages. however. are signilicant. They
`include insensitivity, the requirement
`For large blood samples. and contami-
`nation by other volatile bases that may
`allect the final value. Overall. this pro-
`cedure is laborious and slow and there-
`
`fore is not used routinely.
`
`C0iarintetric/Fluort'ntetrt'c
`Reactiorw
`
`This method is based on the reaction
`
`of ammonia with a reagent to liorrn a
`colored complex that is measured by
`spectrometry or [‘luorometr_y. Among
`the first reactions used was the in-
`
`dophenol reaction, described by Berth-
`elot
`in l85923°:
`the lbrmation oF a
`
`bluish color by the reaction oi‘amrno~
`nia with phenol and hypochlorite. This
`method is commonly reFerred to as the
`phenol reaction. Another colorimetric
`reaction is the Nessler reaction,
`in
`
`which a brown»-orange color is formed
`by the reaction oiiamtnonia with mer-
`Cllry or potassium iodide in an alkaline
`solution. Some other colorimetric reac-
`
`tions include the use oli isocyanurate,
`cyanate, ninhydrin. or thymol hypo-
`bromite. Detection of‘ ammonia and
`
`primary amines down to the nanogram
`range is routinely performed with fluo-
`rescence derivatization reagents such
`
`as lluorescamine and o-phthalalcle-
`h_yde.2"'29 The principle advantages to
`this approach are speed, simplicity,
`specificity when used carei‘ull__v. and ex-
`cellent sensitivity. The disadvantage is
`that other substances in the blood ali-
`
`liect some reactions, For example. the
`Berthelot reaction is inhibited by ex‘-
`cess amino acids. creatine. glutamine.
`and some therapeutic agentsm
`
`Gad-aerwing Electronic
`With the introduction oi‘ the gas-
`sensitive electrode (cg. Orion. Nlodel
`951201), a number ol‘ reports have ap-
`peared describing the methods re-
`quired and the use olithe electrode in
`measuring ammonia levels in samples
`oi‘ blood. urine. cerebrospinal Fluid.
`and saliva over a broad range lirom lU
`p.mol/L to nearly 1 mmol/ L.
`When immersed in the sample or
`held closely above it.
`the dissolved
`gas oi‘ interest diliuses across a gas-
`permeable membrane into a small vol-
`ume ol' bullier. The reaction changes
`the pH oi’ the builier, which is sensed
`by an internal pH electrode or sensing
`electrode. The change in pH results in
`a change in the potential between the
`sensing electrode and a reference elec-
`trode immersed in a separate reference
`bul'l'er, all housed within the same elec-
`
`trode body. The arrangement is illus-
`trated in Fig 4. in which the scale oi‘
`some of‘ the com ponents is exaggerated
`For clarity.
`The main advantages oi‘ electrode-
`based ammonia assay are its cheap-
`
`ness. ease oi‘ use, and because it never
`
`comes in contact with the sample, its
`imperviousness to sample color, tur-
`bidity. viscosity. or the presence oi‘
`dI'ugs or other metabolites in the sam-
`pie. The electrode is best arranged
`above the surface 0}‘ the sample in a
`sealed environment
`(Fig 4). This
`avoids the accumulation oi‘ proteins
`and cell Fragments on the membrane
`surlaee that would normally occur
`during immersion into plasma or blood
`sample and minimizes the loss of am-
`monia Irom the sample away from the
`electrode
`during
`the measure-
`ment.22‘5"52 The disadvantages of the
`electrode-based system include the re-
`quirement oflarge sample volumes and
`slow sample reads. especially at low
`ammonia levels, requiring 10 to ]5
`minutes. In addition. rnaior dill'erences
`in either the osmolarity or temperature
`olithe sample and the sensing electrode
`bullet‘ must be avoided.
`
`Enzymatic Method
`The specificity oi‘ most methods For
`ammonia determination in biologic llu-
`ids relies on the physical separation ol-
`arnmonia from interfering substances
`by volatilization aFter alkalization. ln
`contrast,
`the most common method
`
`used in clinical laboratories is an en:r._y-
`matic method that measures ammonia
`
`directly. Thus sample preparation is
`relatively simple. because the previous
`liberation oiiammonia from the sample
`is not required. This assay is based on
`the reductive amination oi‘ 2-oxoglu~
`
`SI4
`
`4of10
`
`4 of 10
`
`

`

`THE JOURNAL OF PEDIATRICS
`VOLUME I38. NUMBER I
`
`h
`
`sou
`In
`'°°‘m.2$‘i‘lii.. "'°
`He carrier gas
`
`
`air {if bffllih SRITIDH
`
`BARSOTFI
`
`deleellon quadruple
`“mm mm” mass spectrometer
`fl|'|lI'I|'IBflI’0I'I
`IOI1 HEIEGIOF
`
`
`
`ion source
`
`9::
`(9.3. Arfl'|;D)
`
`
`
`Ion Inhcllnrt
`Ion injection
`orlllce
`OHIIBE
`
`lrqecltnn dtfluainn pump
`
`ijl
`10cm
`
`detection cltfltinlon pump
`
`I"i:q 5. Simplified schematic of selected-ion flcw ‘tube (S||'-T).
`
`tarate with glutamate dehydrogenase
`and reduced nicotinamide adenine di-
`
`nucleotide phosphate:
`
`2~Oxoglutarate + NH3 + NADPH
`TlGt.DH
`Glutamate + NADP
`
`The decrease in absorbance at 540
`the
`
`nm caused by
`oxidation of
`NADPH is proportional to plasma am-
`monia. GLDH is specific For ammonia
`and does not react with methylated
`amines. Early studies describing the
`enzymatic determination ol" ammonia
`used NADH as a coenavme. Because
`other NADH-consuming systems are
`present in blood, many of these reports
`overestimate the level of‘ Free ammonia,
`
`for example. iVtuting.53 The eI’l'ect oi‘
`these systems can be minimized. usual-
`ly by a 30-minute prcincubation peri-
`od. There are consideralily lewer
`NADPH—constiming sources in plas~
`ma. so the preincubation time can be
`reduced to a few minutes.5
`
`The assay can be used to measure am-
`monia levels over a broad range. from
`as low as 12 t.tmol.’L to as high as I
`rnrnol/L. The disadvantage of this ap-
`proach is the length and complexity oi‘
`the procedure. thereby enhancing the
`potential for variation in reported blood
`ammonia levels. llinot handled proper-
`ly, ammonia concentrations rise in
`standing blood or plasma. lndecd, be-
`cause standard proccdurcs for pre-
`analysis sample processing do not in-
`corporate any attempts to inhibit the
`
`continued liberation of ammonia from
`
`ods could alert medical stal‘l' to an im-
`
`the samples, except for lowering the
`temperature, ammonia levels in the
`sample will continue to increase during
`the assay and up to the time oiithc ini-
`tial readings. Thus overestimates oFam-
`monia levels are most likely in poorly
`handled samples containing elevated
`levels olltransaminases and alnino acids.
`
`Nor-natal Vafueafor B3003
`Amm.om'a Levels
`Table I lists selected blood ammonia
`
`levels l'or various blood sample types
`and assay methods from a number of
`studies. The average values l‘or arterial
`blood. plasma. venous blood. and plas-
`ma are 18, 23, 28, and 52 ].1molfl., re~
`spectively. The average value For ve-
`nous blood and plasma is 50 tlmol./L.
`
`FUTURE
`
`DEVELOPMENTS
`
`The major limitations ol‘convention-
`in vitro blood ammonia measure-
`
`al
`
`ments are the complexity involved in
`the proper drawing and handling oi‘
`the sample. the time allowed between
`drawing and assaying. and iinally. the
`assay itself. A consequence ol‘ these
`limitations is that blood ammonia mea-
`
`surements are performed only a Few
`times each day. Alternative methods
`are still sought that are noninvasive or
`require a small catheter in a peripheral
`vein but provide a continuous monitor
`oi‘ blood ammonia levels. Such meth-
`
`pending hyperammonemic condition
`and would more easily permit earlier
`selection and regulation oi‘ therapeutic
`interventions. Two promising methods
`that are under development and may
`eventually be used clinically are the se-
`lected-ion llow tube technique, which
`analyzes trace gases in breath. and a
`fiber-optic catheter tipped with an am-
`monia-sensitive indicator.
`
`Selected-for: Flow Tube
`
`Selected-ion Flow Tube is a quanti-
`tative method for the rapid. real-time
`analysis of the trace gas content of‘ at-
`mospheric air. It was originally devel-
`oped to study ionic reactions in the gas
`phase and is particularly valuable
`for providing ltinetics data on ion-
`molecule reactions. contributing to the
`current understanding oi‘ the chem-
`istry ollsomc low-temperature gaseous
`plasmas. especially interstellar clouds.
`The same technology is currently
`being developed to analyze trace gases
`in breath. Previous methods {or mea-
`surement oi‘ ammonia in breath have
`
`required large sampling Iiow rat'es3'l or
`long sampling times35 and are there-
`fore unsuitable For assessing the am-
`monia concentration from a single
`breath. A schematic oi" the SIFT appa-
`ratus is shown in Fig 5 talten from
`Smith and Spaniel.“ This technology is
`being llurthcr developed and may soon
`be a sensitive, quantitative method For
`the continuous real-time analysis ol'the
`trace—gas content ofhuman breath and
`
`S15
`
`5of10
`
`5 of 10
`
`

`

`Bansom
`
`THE _|ouaNAL or PEDIATRICS
`JANUARY 2001
`
`Tobie 1’. Reported assay techniques and blood arnrnonla levels in healthy subjects
`
`Reference
`
`Arterial blood
`
`.
`
`Hutchinson and Labby (1962)
`Gips and Wqbbens-Alberts (1968)
`Huizenga and Cips (1985)
`Huizeuga et al (1992)
`Huizenga et al (1992)
`Arterial plasma
`Crips and \«Vibbens-Alberts (1968)
`Huizenga and Gips (1935)
`Venous blood
`
`Dienst (1961)
`Forman (1964)
`Hutchinson and Labby (1962)
`Proelss and Wright (1973)
`Gips and Wibbens-Albefls (1963)
`McCullough (1967)
`Gangolli and Nicholson (1966)
`Sinniah et al (1970)
`Huizenga et al (1992)
`Huizenga et al (1992)
`Venous plasma
`Gerron et a1 (1976)
`Oberholzer et al (1976)
`Buttery et al (1982)
`Brusilow (1991)
`Cooke and Jensen (1985)
`Willems and Steenssens (1938)
`Spooner et al (1975)
`Seligson and Hirahara (1957)
`Mondzac et a1 (1965)
`Muting er al (1968)
`van Anken and Schiphorst (1974)
`Howanitz et al (1984)
`(:13 Fonseca-Wollheim (1990)
`
`42
`41
`15
`I6
`16
`
`41
`15
`
`2 l
`59
`42
`25
`41
`43
`40
`45
`16
`15
`
`9
`44
`33
`4
`32
`46
`27
`20
`2
`35
`5
`I1
`8
`
`.
`
`Ion-exchange/Nessler
`Supernatant/phenol
`N1icrodif1"usionfBAC I
`Microdiiiiusion/BAC II
`Enzymatic
`
`Supernatant/pl1enol
`Enzymatic
`
`1on—exchange/Nessler
`lon -exchange/phe no]
`lon-exchange/Nessler
`Supernatant/electrode
`Supernatant/phenol
`Supematantfphenol
`Supernatant/phenol
`Supernatant/phenol
`Microdiffixsion/BAC II
`Enzymatic
`
`lon-exchangefphenol
`lon-exchangefphenol
`Ion-exchange/phenol
`Ion-ext: han giefphenol
`Electrode
`Electrode
`Supernatantffluorometry
`Microdif1"usion!Nessler
`Enzymatic
`Enzymatic
`Enzymatic
`Enzymatic
`Enzymatic
`
`19
`22
`3
`21
`21
`
`23
`25
`
`15
`51
`21
`17
`22
`57
`50
`44
`21
`21
`
`19
`16
`21
`13
`44
`44
`52
`56
`30
`57
`22
`50
`29
`
`thus permit a continuous, noninvasive
`measure ofsystemic ammonia levels.
`This technique involves the genera-
`tion of positive ions that are created in
`a microwave discharge ion source,
`containing an appropriate gas mixture.
`In conventional mass spectrometry,
`ionization of the trace gas molecules is
`achieved by electron bombardment.
`resulting in molecular "cracking" and
`the production of complicated spectra.
`The SIFT technique uses a current ol‘
`precursor ions of a given mass-to»
`
`charge ratio. In the case of‘ ammonia
`detection, 1130* is extracted from this
`mixture of ions with a quadrupole
`mass filter. This current oF selected
`
`ions is then injected into a Fast-flowing
`inert carrier gas stream, usually heli-
`urn. The ions are carried along a 1»
`meter length flow tube and are sam-
`pled by a pinhole downstream of the
`injector. The sample of breath is intro-
`duced into the device by a sample port
`near the injector (Fig 5). Accurate
`trace gas analysis or quantification is
`
`possible because the reaction oF the
`primary ions, in this case H504. with
`ammonia is to Form ammonium ions
`
`and water is precisely defined in the
`SI PT. In general, the primary ions cho-
`sen must not react at significant rates
`with the rnaior components 0F the
`breath sample. oxygen, nitrogen,
`water, or carbon dioxide, because such
`
`reactions would saturate the primary
`ions. 111 turn, the primary ions must
`react eliiciently with the trace gases to
`be detected to Form identifiable prod»
`
`S16
`
`6of10
`
`6 of 10
`
`

`

`BARSOTFI
`
`,
`I
`l
`"
`
`~
`
`I
`
`'33:"
`
`:7
`
`.
`
`mm:
`ism:
`
`as
`E’?
`
`is
`
`'9‘
`
`.3
`
`'9
`
`pnacumnrlons
`,.- u
`I
`
`
`
`‘°"
`
`103
`
`O
`03
`-.02
`-‘£2
`:
`3 in:
`0
`O
`
`in‘
`
`1
`
`at
`
`
`l
`.
`.l
`.
`?I3 75 8-0 85 190 95
`15 20 25 30 35 9 -|I5< 55 BD,{>|
`aeetoasilrile
`almeliivmnim
`ta-tmatrmnmirua
`C3!-l13N
`N0}
`[M0]
`I200]
`[300]
`
`Molecular Weight
`
`Ffg 6. Sll-‘I’ spectrum obtained with H30" precursor ions of bmath sampled from patient with
`end-stage renal failure before hemodialysis treatment. Precursor ions and their respective isotopic
`variants are shown as open bars. and product ions are shown as ,f'lled bars. (Reproduced with permis-
`sion from Davies S. Spanel P. Smith D. Qtiantitafive analysis of ammonia on the breath of patients in
`end-stage renal failure. Kidney In‘-.. l997:52:223-28.)
`
`ic questions remain to be addressed
`before the ellicaqy of this approach is
`established, including the correlation
`between breath ammonia levels and
`
`blood levels and the factors determining
`breath ammonia levels. One concern is
`whether breath ammonia is determined
`
`predominantly by urea hydrolysis with
`in the oral cavity. or whether it does
`indeed reflect the level in blood. Prelim-
`
`inary reports by Davies et all? show
`a correlation with the plasma urca lev-
`els alier ingestion of t1I'ca in normal
`volunteers and during hcmodialysis of
`patients with end-stage renal failure.
`suggesting that elevated breath ammo-
`nia levels are generated systemically.
`
`RECOMMENDATIONS
`
`In facilities treating large numbers of
`patients with liver or metabolic disor-
`ders, the establishment ofa separate
`facility is recommended for the han-
`dling. monitoring. and measuring of
`blood ammonia and liver enzyme lev-
`els. This is primarily to minimize errors
`From contamination and Poor or im-
`
`proper sample handling and to im-
`prove overall expertise and thereby the
`reliability of the determinations.
`
`Sampife Praceaafrzg
`Nlore efforts must be made to reduce.
`
`the various
`or preferably eliminate.
`sources ofammonia formation in stand-
`
`ing blood or plasma. lfor example. an
`initial step incorporating an acid pre-
`cipitation with cold perchloric acid be-
`fore blood centrifugation should be fol-
`lowed by ion exchange method in batch
`mode to select and purify the ammoni-
`um ions from the few remaining ammo-
`nia-generat-ing systems in the depre-
`teinated plasma sample.
`
`Away Mateo?
`Multiple time points or serial mea-
`surements, perhaps 5 separate time in-
`tervals of ammonia content, should be
`
`made from the same sample of stand-
`ing plasma. If the increase in ammonia
`level is linear with time. that is, exhibit-
`
`ing zero order kinetics. then linear ex-
`trapolation of the time course to zero
`time provides an estimate ofthe ammo-
`nia level at the time ofcollection.
`
`SI‘!
`
`7of10
`
`THE JOURNAL OF PEDIATRICS
`VOLUME I38. NUMBER I
`
`uct ions. Thus the primary ions and the
`specificity of their interactions with the
`target trace gases in the breath sample
`is a determinant ofthe selectivity ofthe
`method. The identification and quanti-
`tation ofthe products formed are then
`detected by a mass spectrometer.
`Currentl_y, the technique can measure
`trace gases down to a partial pressure
`of approximately l0 ppb. The mean
`value of96U ppb for breath ammonia in
`normal adults was reported in Davies
`et alsf and thus is well above the mini-
`
`mum sensitivity of the apparatus. Fig 6
`shows a spectrum obtained from a
`breath sample taken from a uremic pa-
`tient (end-stage renal failure) before
`hemodialysis. The sample was taken
`and stored in a Teflar bag and then
`transferred to the laboratory For analy-
`sis by SIFT. The molecular weight (x~
`axis) for each molecule identified is
`
`shown at the top of each bar. Open
`bars represent precursor ions. H30‘
`(molecular weight = 19). and their
`water clusters with molecular weights
`of 57. 55. and 73. The solid bars show
`
`the counts for each trace gas. ammoni-
`um ions (molecular weight = 18). and
`their water clusters. with molecular
`
`weights of 36 and 54. The partial pres-
`sures ofammonia and acetone are ele~
`
`vatcd compared with those of healthy
`adults, whereas the levels of ethanol,
`
`methanol, and propanol are normal.
`Amines are present‘ in this sample but
`not in normal breath. The presence of
`acetonitrilc is a clear indicator that the
`
`patient smokes. The technique is rapid
`enough to allow realtime. breath-to-
`breath quantitation of trace gas.
`However, a number oftcchnical hur-
`
`dles remain before the technique can be
`moved from the laboratory into the clin~
`ical setting. First. the equipment is still
`rather large. complicated. and cumber-
`some. Another problem is the preven-
`tion ofammonia loss in the condensate
`
`of respired air before it enters the appa-
`ratus.
`ifhere is no doubt that many
`of these technical problems will be
`overcome with further development.
`Nevertheless. several sig~nlficant' biolog-
`
`7 of 10
`
`

`

`BARSOTT1
`
`CONCLUDING REMARKS
`
`The choice of technique For ammonia
`determination depends predominantly
`on the available equipment. Preanaly-
`sis handling including contamination
`and improper or inadequate proce-
`dures to limit ammonia formation in
`
`the sample before analysis remains the
`main problem or source of "error" in
`accurate determinations of free ammo-
`
`nia levels in blood samples.
`However. whenever high blood am-
`monia levels are detected and consis-
`
`tent with the patients clinical status.
`an alternative method should be avail-
`able and used For verification.
`
`REFERENCES
`].
`
`Olson JA. Anfinsen CE. The crystal-
`lization and characterization of L-
`
`glutamic acid dehydrogenase. J Biol
`Chem l952il97:57-79.
`Mondzac A, Ehrlich GE. Seegmiller
`JE. An enzymatic determination of
`ammonia in biological fluids. J Lab
`Clin Med l965i55c526-3].
`van Anken HC. Schiphorst ME. A iti-
`netic determination of ammonia in plas-
`ma. Clin Chim Acta l974;55:]5l-7.
`. Brusilow SW Determination of urine
`orotate and orotidine and plasma am-
`monium.
`In: Hommes FA. editor.
`Techniques in diagnostic human bio-
`chemical: a laboratory manual. New
`York: Wiley-Liss; 199']. p. 345-7.
`Brusilow SW. Maestri NE. Urea cycle
`disorders: diagnosis, pathophysiology.
`and therapy. Adv Pediatr l996:‘i3:
`127-70.
`Huizenga JR. Tangerman A, Gips
`CH. Determination of ammonia in bio-
`
`iluids. Ann Clin Biochem
`logical
`l.99‘i;5l:529-‘l3.
`Lowenstein JM. Ammonia production
`in muscle and other tissues: the purine
`nucleon‘-:le cycle. Physiol Rev 1972;52:
`532-414.
`da Fonseca-Wollheim F. Preanalytical
`increase OF ammonia in blood speci-
`mens From healthy subjects. Clin Chem
`l990:36:l‘l83-7.
`Gerron C-G, Ansley JD, Isaacs JW.
`Kutner MH. Rudman D. Technical
`pitfalls in measurement of venous plas-
`ma NH3 concentration. Clin Chem
`l976:22:665-6.
`Glasgow AM. Clinical application of
`
`10.
`
`II.
`
`12.
`
`15.
`
`14.
`
`15.
`
`16.
`
`I7.
`
`13.
`
`19.
`
`20.
`
`21.
`
`22.
`
`blood ammonia determination. Lab
`Med l93l;l2:l5l-7.
`Howanitz JH. Howanitz PJ. Skrodz-
`ki CA, Iwanski JA. Influences of spec-
`imen processing and storage condi-
`tions on results for plasma ammonia.
`Clin Chem l93‘l;50:9U5~3.
`Lentner C. Geigy scientific tables. Vol
`3. Physical chemistry composition of
`blood hematology. Somatometric data-
`blocd nitrogenous substances. Basel:
`Ciba-Ceigy Limited: 1984.
`Burg PVD. Moolc HW. A simple and
`rapid method For the determination of
`ammonia in blood. Clin Chim Acta
`l965;8:l6'2-4.
`Conway E, Byrne A. An absorption
`apparatus for the micro-determination
`of certain volatile substances. The
`micro-determination
`of
`ammonia.
`Biochem J l993';27:-1 19-29.
`Huizenga JR. Gips CH. Determina-
`tion oF blood ammonia using the Am-
`monia Checker. Iinn Clin Biochem
`l 935;2U: l 37-9.
`Huizenga J R. Tangerman A. Gips
`CH. A rapid method For blood ammo-
`nia determination using the new blood
`ammonia checker (BAC) II. Clin Chim
`Acta 1992;210:153-5.
`IoseFsohn M. Hicks J

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket